Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CDKN2D | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
mRNA | TMEM139 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
mRNA | EFCAB14 | CCLE | pan-cancer | AAC | 0.2 | 7e-05 |
mRNA | MT-CO1 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
mRNA | SPINT1 | CCLE | pan-cancer | AAC | 0.23 | 8e-05 |
mRNA | RHOV | CCLE | pan-cancer | AAC | 0.2 | 8e-05 |
mRNA | LYPD3 | CCLE | pan-cancer | AAC | 0.22 | 8e-05 |
mRNA | PFDN2 | CCLE | pan-cancer | AAC | -0.18 | 8e-05 |
mRNA | NAV1 | CCLE | pan-cancer | AAC | -0.21 | 8e-05 |
mRNA | FAM83H | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |